Mintz Advises 6th Street on $500M Strategic Financing With Arrowhead Pharmaceuticals
August 10, 2024
August 10, 2024
BOSTON, Massachusetts, Aug. 10 -- Mintz, a law firm, issued the following news release:
Mintz advised global investment firm Sixth Street in a strategic financing agreement with Arrowhead Pharmaceuticals, Inc. to fund innovation and growth opportunities across Arrowhead's pipeline of RNAi therapeutics.
The $500 million senior secured credit facility includes $400 million funded at close with an additional $100 million available at Arrowhead's option, subject to mutual . . .
Mintz advised global investment firm Sixth Street in a strategic financing agreement with Arrowhead Pharmaceuticals, Inc. to fund innovation and growth opportunities across Arrowhead's pipeline of RNAi therapeutics.
The $500 million senior secured credit facility includes $400 million funded at close with an additional $100 million available at Arrowhead's option, subject to mutual . . .